Inventiva (IVA) Amortizatization of Intangibles (2022 - 2025)
Inventiva's (IVA) quarterly Amortizatization of Intangibles came in at -$4.4 million in Q2 2025, down 17.5% year-on-year from -$5.4 million in Q2 2024, and down 6.17% quarter-over-quarter from -$4.2 million in Q4 2024.
Inventiva (IVA) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends
Inventiva's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$4.4 million for Q2 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 17.5% year-over-year to -$4.4 million in Q2 2025; TTM through Jun 2025 was -$4.4 million, a 17.5% decrease from a year earlier, with the FY2024 full-year figure at -$4.2 million, down 14.43% from the prior year.
- Amortizatization of Intangibles slipped to -$4.4 million in Q2 2025 per IVA's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at -$3.2 million in Q4 2022 and bottomed at -$4.4 million in Q2 2025.
- The 4-year median for Amortizatization of Intangibles is -$3.7 million (2024), against an average of -$3.8 million.
- Across the five-year window, Amortizatization of Intangibles dropped 5.83% in 2024 and declined 17.5% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$3.2 million in 2022, then retreated by 12.79% to -$3.6 million in 2023, then declined by 14.43% to -$4.2 million in 2024, then dropped by 6.17% to -$4.4 million in 2025.
- Per Business Quant, the three latest IVA Amortizatization of Intangibles figures stand at -$4.4 million (Q2 2025), -$4.2 million (Q4 2024), and -$3.8 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Inventiva | 854.62 Mn | 854.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -4.42 Mn |
| Jun 30, 2025 | -4.42 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Jun 30, 2024 | -3.76 Mn |
| Jun 30, 2024 | -3.76 Mn |
| Dec 31, 2023 | -3.64 Mn |
| Dec 31, 2023 | -3.64 Mn |
| Jun 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | -3.56 Mn |
| Dec 31, 2022 | -3.23 Mn |
| Dec 31, 2022 | -3.23 Mn |